Orange Book product · Generic (ANDA)
CLONAZEPAM
CLONAZEPAM
At a glance
Jun 28, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 28, 2019
7 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
CLONAZEPAM
Strength
0.125MG
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
AB
Application
ANDA 211033
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLONAZEPAM
- 1997KLONOPIN RAPIDLY DISINTEGRATINGBrand (NDA)
NDA 020813 · ROCHE
- 1997KLONOPINBrand (NDA)
NDA 017533 · CHEPLAPHARM
- 2026CLONAZEPAMGeneric (ANDA)
ANDA 216988 · RUBICON RESEARCH
- 2014CLONAZEPAMGeneric (ANDA)
ANDA 078654 · SUN PHARM INDS INC
- 2006CLONAZEPAMGeneric (ANDA)
ANDA 077856 · PRINSTON INC
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077194 · BARR
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077171 · PH HEALTH
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077147 · ACCORD HLTHCARE
- 2001CLONAZEPAMGeneric (ANDA)
ANDA 075423 · SUN PHARM INDS INC
- 2000CLONAZEPAMGeneric (ANDA)
ANDA 075468 · RUBICON RESEARCH
- 1998CLONAZEPAMGeneric (ANDA)
ANDA 075150 · AUROBINDO PHARMA USA
- 1998CLONAZEPAMGeneric (ANDA)
ANDA 074920 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
